Levine AM, Noy A, Lee J, Tam W, Ramos JC, Henry D, Parekh S, Reid E, Mitsuyasu R, Colley T, Dezube B, Ratner L, Cesarman E, Tulpule A: Liposomal doxorubicin, rituximab, cylosphosphamide, vincristein and prednisone (DR-COP) in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol 2012. In press
Villacres MC, Kono N, Mack WJ, Nowicki MJ, Anastos K, Augenbraun M, Liu C, Landay A, Greenblatt RM, Gange S, Levine AM: Interleukin 10 Responses Are Associated With Sustained CD4 T-Cell Counts in Treated HIV Infection. Jour Infect Dis. 2012; 206: 780-789.
Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue, X, D’Souza G, Watts DH, Levine AM; Castle PE, Colie C, Palefsky JM, Strickler HD: Risk of cervical precancer and cancer among HIV infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA 2012: 308; 362-369.
D’Souza G, Burk R, Zhong Y, Minkhoff H, Massad S, Xue X, Watts H, Anastos K, Palefsky J, Levine AM, Castle P, Strickler H: Cervicovaginal HPV infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and non-oncogenic HPV types in a cohort of HIV positive and HIV negative women. Int J Cancer 2012; 131(6): 1472-8.
Massad LS, Weber KM, Wilson TE, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Levine AM, Watts DH, Evans CT: Correlating knowledge of cervical cancer prevention and human papillomavirus with compliance after colposcopy referral. J Lower Genital Tract Dis. 2012; 16:98-105.
Liu CL, Wang C, Robison E, Levine AM, Gandhi M, Schwartz R, Weber KM, Merenstein D: Short term garlic supplement use and HAART adherence, CD4+ cell counts and HIV viral load. Altern Ther Health Med 2012; 18(1):18-22.
Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH, Wright RL, D’Souza G, Colie C, Strickler HD: Genital warts and vulvar intraepithelial neoplasia: Natural history and effects of treatment and HIV infection. Obstet Gynecol 2011; 118(4):831-9.
Merenstein DJ, Hu HH, Robison E, Levine AM, Greenblatt R, Schwartz R, Weber K, Young M, Sharp G, Liu CL. Relationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection. J Altern Complement Med 2010; 9(16): 989-993.
Hessol NA, Napolitano LA, Smith D, Lie Y, Levine AM, Young M, Cohen M, Minkoff H, Anastos K, D’Souza G, Greenblatt RM, and Goedert JJ. HIV Tropism and Decreased Risk of Breast Cancer. PLoS ONE 2010; 5(12):e14349. PMC3002931
Yin MT, Shi Q, Hoover DR, Anastos K, Sharma A, Young M, Levine AM, Cohen MH, Shane E, Golub ET, and Tien PC. Fracture incidence in HIV-infected women: results from the Women’s Interagency HIV Study. AIDS 2010; 24(17):2679-2686.
Massad LS, Evand C, Weber K, Goderre J, Hessol N, Henry D, Colie C, Strickler H, Levine AM, Watts DH, Wilson T: Changes in knowledge of cervical cancer prevention and human papillomavirus among women with HIV, 2006-2008. Obstet Gynecol 2010;116(4):941-947.
D’Souza G, Palefsky JM, Zhong Y, Minkoff H, Massad LS, Anastos K, Levine AM, Moxley M, Xue XN, Burk RD, Strickler HD: Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV seropositive or HIV seronegative women. Cancer Epidemiol Biomarkers Prev 2010: 10 (3): 869-872. PMC2874245
Massad LS, Agniel D, Minkoff H, Watts DH, D’Souza G, Levine AM, Darragh TM, Young M, Cajigas A, Weber K. Effect of Stress and Depression on the Frequency of Squamous Intraepithelial Lesions. Journal of Lower Genital Tract Disease 2010; 15:42-47.
Xue X, Gange S, Zhong Y, Burk R, Minkoff H, Massad LS, Watts DH, Kuniholm M, Anastos K, Levine AM, D’Souza G, Moxley M, Palefsky J, Strickler H: Marginal and mixed effects models in the analysis of HPV natural history data. Ca Epidem, Biomarkers & Prevention 2010: 19 (1) 159-169. PMC 2839537
Frederick T, Burian P, Mack W, Terrault N, Cohen M, Augenbraun M, Young M, Kovacs A, Levine AM: Factors associated with prevalent hepatitis C infection among HIV infected women with no reported history of injection drug use: The Women’s Interagency HIV Study (WIHS). AIDS Patient Care and STDs. In press, 7/09.
Massad LS, Evans CT, Wilson TE, Goderre JL, Hessol NA, Hendry D, Colie C, Strickler H, Levine AM, Watts DH, Weber, KM: Knowledge of cervical cancer prevention and human papillomavirus among women with the human immunodeficiency virus infection. Gynecologic Oncology 2010: 117: 70-76
Sparano JA, Lee J, Kaplan LD, Levine AM, Ramos JC, Ambinder R, Wachsman W, Aboulafia D, Noy A, Henry D, Von Roenn J, Dezube B, Remick S, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn AM, Mitsuyasu R: Rituximab plus concurrent infusional EOPOCH chemotherapy is highly effective without excessive toxicity in HIV associated, B cell non-Hodgkin’s lymphoma. Blood 2010; 15:3008-3016.
Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watt DH: HIV as a risk factor for lung cancer in women: Data from the Women’s Interagency HIV Study (WIHS). J Clin Oncol 2010; 28:1514-19.
Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH, Levine AM, Wright RL, Colie C, D’Souza G, Massad LS, Strickler HD: Influence of adherent and effective antiretroviral therapy use of human papillomavirus infection and squamous intraepithelial lesions in Human Immunodeficiency Virus-Positive Women. J Infect Dis 2010; 201:681-690. PMC 2818607
Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF: Effects of chemotherapy in AIDS-associated non-Hodgkin’s lymphoma on KSHV DNA in blood. J Clin Oncol 2009; 27:2496-502.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 11/12.
